Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients

Donihi, Amy Calabrese, Raval, Ditina, Saul, Melissa, Korytkowski, Mary T., DeVita, Michael A.·2006·Endocrine Practice

Cited by (244)

Items 101–200 of 244

  1. Analysis of Glucocorticoid-Related Genes Reveal CCHCR1 as a New Candidate Gene for Type 2 Diabetes
    Laura N. Brenner, Josep Maria Mercader, Catherine C. Robertson, Joanne B. Cole, Ling Chen, Suzanne B.R. Jacobs, Stephen S. Rich, José C. Florez · 2020 · Journal of the Endocrine Society
  2. Management of the Hospitalized Patient With Type I Diabetes Mellitus
    Carlos E. Mendez, Guillermo E. Umpierrez · 2013 · Hospital Practice
  3. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly
    Marco Giorgio Baroni, Francesco Giorgino, VINCENZO PEZZINO, Carla Maria Scaroni, Angelo Avogaro · 2016 · Nutrition Metabolism and Cardiovascular Diseases
  4. Diurnal profile of interstitial glucose following dexamethasone prophylaxis for chemotherapy treatment of gynaecological cancer
    Marcus J. Lyall, I. Thethy, L Steven, Melanie Mackean, Fiona Nussey, M. Sakala, Tzyvia Rye, M. W. J. Strachan, Anna R. Dover · 2018 · Diabetic Medicine
  5. Non-Diabetic Hyperglycemia in the Pediatric Age: Why, How, and When to Treat?
    Valentina Fattorusso, Rosa Nugnes, Alberto Casertano, Giuliana Valerio, Enza Mozzillo, Adriana Franzese · 2018 · Current Diabetes Reports
  6. Review of Health Hazards and Toxicological Effects of Constituents of Cosmetics
    John Kanayochukwu Nduka, Henrietta Ijeoma Kelle, Isaac Omoche Odiba · 2019 · IntechOpen eBooks
  7. Hospital hypoglycemia: From observation to action
    Haritha Bellam, Susan Shapiro Braithwaite · 2010 · Insulin
  8. Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases
    Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos · 2021 · Pharmacological Reports
  9. Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: management of steroid-exacerbated hyperglycemia
    Cheng, Yu-Chien, Guerra, Yannis, Morkos, Michael, Tahsin, Bettina, Onyenwenyi, Chioma, Fogg, Louis, Fogelfeld, Leon · 2021 · PLOS ONE
  10. The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
    Mengjun Liang, Liping Xiong, Aihua Li, Jiafan Zhou, Yajuan Huang, Miao-Fang Huang, Xing Zhang, Hongrui Shi, Ning Su, Yi Wei et al. · 2022 · BMC Nephrology
  11. Physician's attitudes towards diagnosing and treating glucocorticoid induced hyperglycaemia: Sliding scale regimen is still widely used despite guidelines
    Maaike C. Gerards, E C Cohen Tervaert, Joost B.L. Hoekstra, Titia M. Vriesendorp, Victor E. A. Gerdes · 2015 · Diabetes Research and Clinical Practice
  12. Future technology-enabled care for diabetes and hyperglycemia in the hospital setting
    Alex Renato Montero, Jeffrey S. Dubin, Paul Sack, Michelle Fischmann Magee · 2019 · World Journal of Diabetes
  13. An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation
    Kathryn L. Hackman, Gregory I. Snell, Leon A. Bach · 2012 · The Journal of Heart and Lung Transplantation
  14. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
    Neil M. Iyengar, Joyce O’Shaughnessy, Heather Moore, Erika Paige Hamilton, Komal L. Jhaveri, Cynthia X. Ma, Karen L. Tedesco, Monali K. Vasekar, Sarah Donahue, Hope S. Rugo · 2025 · npj Breast Cancer
  15. Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations
    Thiago Bosco Mendes, Alexandre Barbosa Câmara de Souza, Bruno Halpern · 2022 · Diabetology & Metabolic Syndrome
  16. Use Of Nph Insulin For Glucocorticoid-Induced Hyperglycemia
    Cecilia C. Low Wang, Boris Draznin · 2016 · Endocrine Practice
  17. Pharmacists' role in glycemic management in the inpatient setting: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy
    Amy Calabrese Donihi, John Michael Moorman, Alicia Abla, Raja Hanania, Dustin Carneal, Heidemarie Windham MacMaster · 2018 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  18. Effect of short-term prednisone on beta-cell function in subjects with type 2 diabetes mellitus and healthy subjects
    M. Shah, Mayada Adel, Bettina Tahsin, Yannis Guerra, L. Fogelfeld · 2020 · PLoS ONE
  19. Practical implications of the revised guidelines for inpatient glycemic control
    Jodie A. Reider, Amy Calabrese Donihi, Mary T. Korytkowski · 2009 · Polskie Archiwum Medycyny Wewnętrznej
  20. Applicability of a Newly Developed Bioassay for Determining Bioactivity of Anti-Inflammatory Compounds in Release Studies − Celecoxib and Triamcinolone Acetonide Released from Novel PLGA-Based Microspheres
    Hsiao-yin Yang, Maarten van Dijk, Ruud Licht, Michiel Beekhuizen, Mattie H.P. van Rijen, Martina Källrot, F. Cumhur Öner, Wouter J.A. Dhert, Detlef Schumann, Laura B. Creemers · 2014 · Pharmaceutical Research
  21. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations
    Chelsea S. Davis, Anna Faino, Frankline Onchiri, Ronald L. Gibson, Lina Merjaneh, Bonnie W. Ramsey, Margaret Rosenfeld, Jonathan D. Cogen · 2022 · Annals of the American Thoracic Society
  22. Consensus evidence-based guidelines for in-patient management of hyperglycaemia in non-critical care setting as per Indian clinical practice.
    Kalyan Kumar Gangopadhyay, Ganapathi Bantwal, Pradeep Talwalkar, Arumugam Muruganathan, Ashok Kumar Das · 2014 · PubMed
  23. Fasting Blood Glucose Level in Locally Advanced Non-Small Cell Lung Cancer: a New Prognostic Factor?
    Esra Korkmaz Kıraklı, Ufuk Yılmaz, Hasan Yilmaz, Berna Eren Komurcuoglu · 2018 · Hormones and Cancer
  24. Glycemic Management in the Inpatient Setting
    Lowell R. Schmeltz, Carla Ferrise · 2012 · Hospital Practice
  25. Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity
    Gerui Li · 2020 · Diabetes Research and Clinical Practice
  26. Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
    Elisa K. Liu, Varshini Vasudevaraja, Vladislav O. Sviderskiy, Yang Feng, Ivy Tran, Jonathan Serrano, Christine Cordova, Sylvia Christine Kurz, John G. Golfinos, Erik P. Sulman et al. · 2022 · Neuro-Oncology Advances
  27. Diabetic Kidney Disease in Post-Kidney Transplant Patients
    Ngoc-Yen T. Pham, Diego Cruz, Luis Madera Marin, Raja Ravender, Pablo García · 2024 · Journal of Clinical Medicine
  28. Role of Steroids in Refractory Hypoglycemia Due to An Overdose of 10,000 Units of Insulin Glargine: A Case Report and Literature Review
    Komal Tariq, Saira Tariq, Amanda M. Denney Queen · 2017 · AACE Clinical Case Reports
  29. Steroid-Induced Diabetic Ketoacidosis: A Case Report and Review of the Literature
    Megan M Cavataio, Clifford D. Packer · 2022 · Cureus
  30. Preoperative Hypoglycemia in a Patient Receiving Insulin Detemir
    Ronald P. Olson, Mary Angelyn Bethel, Lillian F. Lien · 2009 · Anesthesia & Analgesia
  31. Achieving Glycemic Control in Special Populations in Hospital: Perspectives in Practice
    ALICE Y.Y. CHENG · 2014 · Canadian Journal of Diabetes
  32. Update on Glucose Management Among Noncritically Ill Patients Hospitalized on Medical and Surgical Wards
    Tina Gupta, Margo Hudson · 2017 · Journal of the Endocrine Society
  33. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study
    Sheng‐Hwu Hsieh, Jen‐Der Lin, Hung-Yu Cheng, Cheng Ho, Miaw‐Jene Liou · 2006 · Clinical Therapeutics
  34. Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
    Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Alexandre Barbosa Câmara de Souza, Juliana C. Pereira, Ana O. Hoff, Márcia Nery · 2022 · Einstein (São Paulo)
  35. LLY-2707, A Novel Nonsteroidal Glucocorticoid Antagonist That Reduces Atypical Antipsychotic–Associated Weight Gain in Rats
    Dana K. Sindelar, Mathew W. Carson, Michelle Morin, Janice Shaw, Robert J. Barr, Anne B. Need, Jesline T. Alexander-Chacko, Michael J. Coghlan, Donald R. Gehlert · 2013 · Journal of Pharmacology and Experimental Therapeutics
  36. Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care
    Timothy W. Valk, Carol McMorrow · 2020 · SAGE Open Medicine
  37. The effect of metformin on glucose metabolism in patients receiving glucocorticoids
    Dylan M. Landis, Alex Sutter, Fabiana Fernandez, KENNETH M. NUGENT · 2022 · The American Journal of the Medical Sciences
  38. Glucose Disturbances and Atypical Antipsychotic Use in the Intensive Care Unit
    Amy Bishara, Stephanie V. Phan, Henry Nolan Young, T. Vivian Liao · 2015 · Journal of Pharmacy Practice
  39. Fasting Plasma Glucose Levels Predict Steroid-Induced Abnormal Glucose Metabolism in Patients with Non-Diabetic Chronic Kidney Disease: A Prospective Cohort Study
    Xiaobing Yang, Xin Lin, Tao Lu, Pingyan Chen, Xiaobin Wang, Fan Fan Hou · 2015 · American Journal of Nephrology
  40. Obstacles to Optimal Management of Inpatient Hyperglycemia in Noncritically Ill Patients
    Ambreen Qureshi, Dee A. Deakins, L. Raymond Reynolds · 2012 · Hospital Practice
  41. Chronic Physiological Hypoxia and High Glucose Concentration Promote Resistance of T98G Glioblastoma Cell Line to Temozolomide
    Anna Bielecka · 2014 · Drug Designing Open Access
  42. Management of Glucocorticoid-Induced Hyperglycemia in Cancer Patients: A Feasibility Study
    Jenny Wright, Theresa Nielsen, Samantha Burns, Nicole Weekes, Anisha Pradhan, Judeil Krlan Teus, Gemma McErlean · 2024 · Clinical Nursing Research
  43. Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma
    Andreja Marić, Tanja Miličević, Jelena Vučak Lončar, Davor Galušić, Maja Radman · 2020 · International Journal of General Medicine
  44. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis
    Gabriella Varga, Melinda Ugocsai, Petra Hartmann, Norbert Lajkó, Réka Molnár, Szilárd Szűcs, Dávid Kurszán Jász, Dániel Érces, Miklós Ghyczy, Gábor K. Tóth et al. · 2017 · Inflammopharmacology
  45. Manejo de la hiperglucemia en el paciente hospitalizado
    María Guadalupe Castro-Martínez, Sergio Gutiérrez, María Gabriela Liceaga Craviotto, Graciela Alexánderson Rosas, Ricardo Cabrera Jardines, Raúl Carrillo Esper, Jorge Escobedo, Jorge García Méndez, María Guadalupe Mercadillo-Pérez, Carlos Ortega González et al. · 2012 · Medicina Interna de México
  46. Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
    M.M.J. Zanders, Harm Reinout Haak, Myrthe P. P. van Herk‐Sukel, Ron M. C. Herings, Lonneke Veronique van de Poll-Franse, Jeffrey A. Johnson · 2017 · Diabetes & Metabolism
  47. Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD)
    Emerson Cestari Marino, Denise Momesso, Marcos Tadashi Kakitani Toyoshima, Maria Fernanda Ozorio de Almeida, Beatriz D'Agord Schaan, Leandra Anália Freitas Negretto, Augusto Cezar Santomauro Junior, Priscilla Cukier, Paulo Genestreti, Alina Coutinho Rodrigues Feitosa et al. · 2025 · Diabetology & Metabolic Syndrome
  48. In-silico Screening of Phytoconstituents on Wound Healing Targets - Approaches and Current Status
    Asha Byju Thomas, Vijaya Mandale, Ravindra D. Wavhale, Sohan S. Chitlange · 2021 · Current Drug Discovery Technologies
  49. BARLERIA MONTANA WIGHT AND NEES–A PROMISING NATURAL ANTI-INFLAMMATORY AGENT AGAINST FORMALIN INDUCED INFLAMMATION
    Sriram Sridharan, M. Venkatramani, Kavitha Janakiraman, Brindha Pemiah, Sasikumar Chinnagounder · 2015 · International Journal of Pharmacy and Pharmaceutical Sciences
  50. Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital
    Tak Kyu Oh, In‐Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee‐Joon Bae, You Hwan Jo · 2019 · Annals of Intensive Care
  51. The critical need for guidance in managing glycaemic control in patients with cancer
    Edward L. Giovannucci · 2021 · Diabetic Medicine
  52. Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c
    Caitlyn Gordon, Barbara Kamel, Lauren McKeon, Danielle Brooks, Rifka Schulman‐Rosenbaum · 2022 · Diabetes Epidemiology and Management
  53. Anti-inflammatory screening of ethanolic leaf extract of Vernonia arborea Buch. –Ham.in formalin induced albino wistar rats
    Sriram Sridharan, Meenaa Venkatramani, Kavitha Janakiraman, Brindha Pemiah, Sasikumar Chinnagounder · 2016 · Indian Journal of Pharmaceutical Education and Research
  54. The hospital pharmacist: an integral part of the hyperglycaemic management team
    Paul M. Szumita · 2009 · Journal of Clinical Pharmacy and Therapeutics
  55. Differential effects of oral versus intravenous hydrocortisone and dexamethasone on capillary blood glucose levels in adult inpatients − a single centre study
    Vaishali Limbachia, Ian Nunney, Daniel J. Page, Hannah A. Barton, Leena K. Patel, Georgia N. Thomason, Stephan L. Green, Kieran F.J. Lewis, Ketan Dhatariya · 2024 · Clinical Medicine
  56. Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus
    Yung‐Chih Kuo, Sourav De · 2024 · Journal of the Taiwan Institute of Chemical Engineers
  57. Postoperative outcomes of biopsy versus debulking surgery for immunoglobulin G4-related ophthalmic disease: a retrospective comparative study
    Rikako Iwasaki, Yoshiyuki Kitaguchi, Takeshi Morimoto, Kohji Nishida · 2025 · Japanese Journal of Ophthalmology
  58. Molecularly imprinted polymers for corticosteroids: impact of polymer format on recognition behaviour
    Laurence Fitzhenry, Panagiotis Manesiotis, Patrick Duggan, Peter McLoughlin · 2013 · Microchimica Acta
  59. Trastorno psicótico inducido por glucocorticoides: descripción de 2 casos clínicos y revisión de la literatura
    Mariana Isabel Herazo-Bustos, Soraya Aparicio-Turbay, Liliana Patarroyo-Rodríguez · 2016 · Psiquiatría Biológica
  60. Management of Glucocorticoid‐Induced Diabetes and/or Hyperglycemia
    Han Na Kim, Nestoras Nicolas Mathioudakis · 2018
  61. Impact of type 2 and steroid-Induced diabetes mellitus on prognosis in patients with multiple myeloma
    Jiheng Wang, Pu Xiang, Erjiang Zhao, Lina Liu, Yuzhang Liu, Li-Jie Liang, Yushan Cui, Baijun Fang · 2025 · World Journal of Surgical Oncology
  62. Basal-bolus insulin therapy for the treatment of non-critically ill patients with type 2 diabetes in Vietnam: effectiveness and factors associated with inpatient glycemic control
    Mai Ngoc Thi Tran, Khiem Tran Dang, Luong Dai Ly, Nam Quang Tran · 2022 · International Journal of Diabetes in Developing Countries
  63. The protective effect of imatinib against pancreatic β-cell apoptosis induced by dexamethasone via increased GSTP1 expression and reduced oxidative stress
    Namoiy Semprasert, Petcharee Maneethorn, Suwattanee Kooptiwut · 2024 · Scientific Reports
  64. Critical Care Diabetes Education
    Judy Keaveny · 2013 · Critical Care Nursing Clinics of North America
  65. Management of Steroid-induced Hyperglycemia
    Sunghwan Suh, Mi Kyoung Park · 2016 · Journal of Korean Diabetes
  66. High-Dose Glucocorticoid Treatment Does Not Induce Severe Hyperglycemia in Young Patients with Autoimmune Diseases by Cgms
    Yin g. Zhou, Yan Zhao, Tao Yuan, Nan Jiang, Yingyue Dong, Yunjiao Yang, Li. Wang, Jiuliang Zhao, Le Min, Weigang Zhao · 2017 · Endocrine Practice
  67. Complications Associated with Glucocorticoids Treatment in Critically Ill Patients
    Paola Confalonieri, Nicolò Reccardini, Stefano Kette, Francesco Salton · 2025 · Seminars in Respiratory and Critical Care Medicine
  68. Overview and Management of Glucocorticoid-Induced Hyperglycemia in Pulmonary Diseases: Insight into the COVID-19 Pandemic
    Danielle Brooks, Carol Joan Levy · 2021 · INTERNATIONAL JOURNAL OF DIABETES & METABOLIC SYNDROME
  69. The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis
    Panteleimon Pantelidis, Parmenion P. Tsitsopoulos, Eleni T. Pappa, Elpida Theologou, Nikolaos Karanikolas, Christos Drosos, Christos A. Tsonidis · 2019 · Clinical Neurology and Neurosurgery
  70. Drug-induced hyperglycemia
    Ol'ga Dmitrievna Ostroumova, Акимова Елизавета Сергеевна, А. И. Кочетков · 2019 · Clinical pharmacology and therapy
  71. Glucose intolerance in intensive care patients: Incidence and outcome
    Ahmed A El Shebiny, Gamal M Elewa, Ez Alregal G. Gouda, Reham Mustafa Hashim · 2020 · Egyptian Journal of Anaesthesia
  72. Misuses and side effects of steroids derivatives
    Nemah Hassone Mahdi Aljubori · 2019 · Aalborg Academy Journal of Medical Sciences
  73. Prevention of Hyperglycemia
    Lucy A. Ochola, Eric M. Guantai · 2021 · IntechOpen eBooks
  74. The Efficacy of Varied Oral Steroid Doses on the Treatment of Sudden Sensorineural Hearing Loss
    Chenlin Liu, Kuen‐Yao Ho, Ling‐Feng Wang, Chen‐Yu Chien, Hsun‐Mo Wang · 2014 · The Journal of International Advanced Otology
  75. Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes
    Catherine Li, Patricia Krause, Gretchen M. Stern · 2021 · Endocrine
  76. A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia
    Alexander B. Karol, Natalia Viera, SELASSIE J. OGYAADU, Danielle Brooks, Nirali A. Shah, Anne S. Linker, David Wing-Hang Lam, Carol Joan Levy, Grenye O’Malley · 2023 · Clinical Diabetes
  77. Necrotizing Fasciitis—Severe Complication of Bullous Pemphigoid: A Systematic Review, Risk Factors, and Treatment Challenges
    Milan Stojičić, Milana Jurišić, Milana Marinković, Miodrag Lj. Karamarković, Milan Jovanović, Jelena Jeremić, Marko S. Jović, Aleksandar M. Vlahovic, Mladen Jovanović, Kristina Radenović et al. · 2023 · Medicina
  78. Public awareness of side effects of systemic steroids in Asir region, Saudi Arabia
    Nouf Alhammadi, Saud Mushabbab Mohammed Al Oudhah, Mofareh Ahmed Asiri, Mohammed Abdullah Alshehri, Bassam Ahmed B. Almutairi, Abdullah Mohammed Abdullah Thalibah, Fahad Nasser Mohammed Asiri, Abdullah Alshahrani · 2023 · Journal of Family Medicine and Primary Care
  79. Safety of steroids in severe community-acquired pneumonia
    Federica Viola Piedepalumbo, Ana Motos, Francesco Blasi, Antoní Torres · 2025 · European Respiratory Review
  80. The Risk of Type 2 Diabetes among Older Asian, Native Hawaiian, and Pacific Islander Colorectal Cancer Survivors: A Population-Based Study Using the SEER–Medicare Database
    Kuang‐Yu Liu, Chun-Pin E. Chang, Shane A. J. Lloyd, Randa Tao, Timothy Nguyen, Zuo‐Feng Zhang, Mia Hashibe · 2025 · Cancer Epidemiology Biomarkers & Prevention
  81. Incretin-Based Therapies: Review of the Outpatient Literature with Implications for Use in the Hospital and After Discharge
    Bruce W. Bode, Alpesh Amin · 2009 · Hospital Practice
  82. Are they high on steroids? Tailored interventions help improve screening for steroid-induced hyperglycaemia in hospitalised patients
    Punith Kempegowda, Alana Livesey, Laura McFarlane-Majeed, Joht Singh Chandan, Theresa Smyth, Martha Stewart, Karen Blackwood, Michelle L. McMahon, Anitha Vijayan Melapatte, Sofia Salahuddin et al. · 2018 · BMJ Open Quality
  83. Glucocorticoid‐induced diabetes among people without diabetes: a literature review
    Majid Alabbood, Min Ling, Kenneth Ho · 2018 · Practical Diabetes
  84. Effects of steroid stewardship on glycemic control in acute exacerbations of chronic obstructive pulmonary disease patients
    Jennifer L. Cole · 2023 · The Clinical Respiratory Journal
  85. The role of osteocalcin in mechanism of Steroid induced diabetes mellitus
    Avinash Holla, Vidyasagar Sudha, Bairy Laxminarayan, B. Nandakrishna, Barkur Ananthakrishna Shastry, Kamath Asha, Manjunath Hande, Adiga Shalini · 2020 · International Journal of Diabetes in Developing Countries
  86. Steroids Induced Hyperglycemia: Its Effects and Management
    N. Akshaya, Ravi Krishna, Nallasamy Venkateswaramurthy · 2023 · Journal of Drug Delivery and Therapeutics
  87. Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study
    Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang · 2024 · SAGE Open Medicine
  88. Interplay Between Diabetes, Obesity and Glioblastoma Multiforme, and the Role of Nanotechnology in Its Treatment
    Sourav De, Sabyasachi Banerjee, Gourab Dey, Subhasis Banerjee, S.K. Ashok Kumar · 2025 · Journal of Nanotheranostics
  89. Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study
    Angela Chen, Anjana Radhakutty, Campbell Henry Thompson, Morton G. Burt · 2025 · BMJ Open Diabetes Research & Care
  90. Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Following Ophthalmic Steroid Use: A Rare Etiology
    Raad Alwithenani, Nasser Al Shanbari, Abdullah Alshamrani, Waad M Malibarey, Yasser S. Alghamdi, Ammar Dawood Alzoriri, Bandar M Alotaibi · 2026 · Cureus
  91. Type 2 Diabetes and Concomitant Illness
    Kathleen Marie Dungan, Elizabeth Harris, Susan Shapiro Braithwaite · 2008 · Humana Press eBooks
  92. Prise en charge du diabète en milieu hospitalier
    Robyn L. Houlden, Sarah E. Capes, MAUREEN A. CLEMENT, David B. Miller · 2013 · Canadian Journal of Diabetes
  93. Etiology of Hyperglycemia in Hospitalized Patients Using the A1C Test
    Svetlana Katsnelson, Erjola Balliu, Ayse Bag Ozbek, Anna Schiwek, Sheela Lohiya, Deepa Aravind, Ronald Patiag, Shai Gavi, Marina M. Charitou · 2013 · Clinical Diabetes
  94. The Wrath of Steroids in Elderly Patients with Pulmonary Diseases
    Angela K. Beckert, Edmund H. Duthie · 2016 · Current Geriatrics Reports
  95. Corticosteroids in the Critically Ill Patient
    Otavio Ranzani, Fernando Godinho Zampieri, Pedro Caruso, Antoní Torres · 2015 · Clinical Pulmonary Medicine
  96. Medications affecting glycemic control
    Ghazwa B. Korayem · 2017 · Integrative Clinical Medicine
  97. Inpatient Management of Diabetes and Hyperglycemia
    William B. Horton · 2019 · Springer eBooks
  98. Multidisciplinary Diabetes Management and Education Strategies in the Inpatient Rehabilitation Setting
    Christopher L. Greer, Joshua J. Neumiller · 2024 · Diabetes Spectrum
  99. Targeted siRNA Delivery Methods for RNAi-Based Therapies
    Di Chen · 2013 · Scholarship@Western (Western University)
  100. Predictors of suboptimal glycemic control for hospitalized patients with diabetes: Targets for clinical action
    Miriam Bender, Tyler C. Smith, Jacqueline Thompson, Ameen Koucheki, Kalman E. Holdy · 2015 · eScholarship (California Digital Library)